TP53 and glioblastoma: To assess if the targeted knockdown of tumor suppressor genes would generate glioblastoma-like histology in vitro, we targeted the following tumor suppressor genes, which have been identified as driver mutations in patient tumors: TP53, PTEN, and NF1 (33, 34).